dimethylphenylpiperazinium iodide has been researched along with Asthma, Bronchial in 3 studies
Dimethylphenylpiperazinium Iodide: A selective nicotinic cholinergic agonist used as a research tool. DMPP activates nicotinic receptors in autonomic ganglia but has little effect at the neuromuscular junction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murad, HA | 1 |
| Hasanin, AH | 1 |
| Watson, BM | 1 |
| Oliveria, JP | 1 |
| Nusca, GM | 1 |
| Smith, SG | 1 |
| Beaudin, S | 1 |
| Dua, B | 1 |
| Watson, RM | 1 |
| Assayag, EI | 1 |
| Cormier, YF | 1 |
| Sehmi, R | 1 |
| Gauvreau, GM | 1 |
| Blanchet, MR | 1 |
| Israël-Assayag, E | 1 |
| Cormier, Y | 1 |
1 trial available for dimethylphenylpiperazinium iodide and Asthma, Bronchial
| Article | Year |
|---|---|
Inhibition of allergen-induced basophil activation by ASM-024, a nicotinic receptor ligand.
Topics: Adult; Aged; Asthma; Basophils; Cross-Over Studies; Dimethylphenylpiperazinium Iodide; Double-Blind | 2014 |
2 other studies available for dimethylphenylpiperazinium iodide and Asthma, Bronchial
| Article | Year |
|---|---|
The anti-inflammatory effects of 1,1 dimethyl-4-phenylpiperazinium (DMPP) compared to dexamethasone in a guinea pig model of ovalbumin induced asthma.
Topics: Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Dexa | 2014 |
Modulation of airway inflammation and resistance in mice by a nicotinic receptor agonist.
Topics: Airway Resistance; Analysis of Variance; Animals; Asthma; Biopsy, Needle; Bronchial Hyperreactivity; | 2005 |